Tae Won Kim
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumab (NCT04954339) | Tae Won Kim | 2021-10-29 |
| The Efficacy and Safety of CKD516 Combined With Durvalumab in Patient Refractory Solid Tumors (NCT04696848) | Tae Won Kim | 2021-02-24 |
Track Tae Won Kim automatically
Every clearance here is in the API, with alerts when new ones post.